Document is current

Any future updates will be listed below

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration

Crossref DOI link: https://doi.org/10.1038/s41598-025-15194-3

Published Online: 2025-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark